» Authors » Tarciana Grandi

Tarciana Grandi

Explore the profile of Tarciana Grandi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 52
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rispoli T, Rodrigues G, Prado M, Pinto L, Rodrigues M, Dullius C, et al.
Mol Biol Rep . 2020 Jul; 47(8):6463-6469. PMID: 32712854
Cystic fibrosis (CF) is a genetic disease caused by variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. There are over 2,000 different pathogenic and non-pathogenic variants described in...
2.
Rispoli T, Rodrigues G, de Castro S, Prado M, Silva C, Grandi T, et al.
Mol Diagn Ther . 2020 Mar; 24(3):315-325. PMID: 32185651
Introduction: The incorporation of molecular genetic testing into cystic fibrosis (CF) screening programs increases the specificity of the diagnostic strategy and has the potential to decrease the rate of false-...
3.
Rispoli T, Castro S, Grandi T, Prado M, Filippon L, da Silva C, et al.
J Pediatr . 2018 May; 199:272-277.e3. PMID: 29731357
Cystic fibrosis newborn screening was implemented in Brazil by the Public Health System in 2012. Because of cost, only 1 mutation was tested - p.Phe508del. We developed a robust low-cost...
4.
Kopacek C, Prado M, Silva C, de Castro S, Beltrao L, Vargas P, et al.
J Pediatr (Rio J) . 2018 May; 95(3):282-290. PMID: 29715434
Objective: To describe the results obtained in a neonatal screening program after its implementation and to assess the clinical and molecular profiles of confirmed and suspicious congenital adrenal hyperplasia cases....
5.
Prado M, Castro S, Kopacek C, de Mello M, Rispoli T, Grandi T, et al.
Mol Diagn Ther . 2017 Aug; 21(6):663-675. PMID: 28819757
Background: Steroid 21-hydroxylase deficiency due to CYP21A2 gene mutations represents more than 90% of all congenital adrenal hyperplasia cases. This deficiency is screened by measuring levels of 17-hydroxyprogesterone, which may...
6.
Costi C, Grandi T, Halon M, Silva M, da Silva C, Gregianini T, et al.
Mem Inst Oswaldo Cruz . 2017 Mar; 112(4):255-259. PMID: 28327789
Background: Porto Alegre is the Brazilian state capital with second highest incidence of tuberculosis (TB) and the highest proportion of people infected with human immunodeficiency virus (HIV) among patients with...
7.
Gusatti C, Costi C, de Medeiros R, Halon M, Grandi T, Medeiros A, et al.
J Med Virol . 2016 Mar; 88(10):1759-66. PMID: 26959287
A number of studies have demonstrated associations between cytokine gene polymorphisms and outcome of hepatitis B virus (HBV) infection. However, no general consensus has been reached, possibly due to differences...
8.
Gusatti C, Costi C, Halon M, Grandi T, Medeiros A, Silva C, et al.
PLoS One . 2015 Aug; 10(8):e0135816. PMID: 26275046
Hepatitis B virus genotype A1 (HBV/A1), of African origin, is the most prevalent genotype in Brazil, while HBV/F predominates in the other South American countries. However, HBV/D is the most...
9.
Grandi T, da Silva C, Amaral K, Picon P, Costi C, Fre N, et al.
Mem Inst Oswaldo Cruz . 2014 May; 109(3):345-51. PMID: 24789557
Certain host single nucleotide polymorphisms (SNPs) affect the likelihood of a sustained virological response (SVR) to treatment in subjects infected with hepatitis C virus (HCV). SNPs in the promoters of...
10.
Grandi T, da Silva C, Amaral K, Picon P, Costi C, Fre N, et al.
Mem Inst Oswaldo Cruz . 2013 Feb; 108(1):48-53. PMID: 23440114
A single-nucleotide polymorphism (SNP) upstream of interleukin (IL)28B was recently identified as an important predictor of the outcome of chronic hepatitis C patients treated with pegylated interferon plus ribavirin (PEG-IFN/RBV)....